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Major histocompatibility complex (MHC) class II alleles HLA-DQ8 and the mouse homologue I-A g7 lacking a canonical aspartic acid residue at position b57 are associated with coeliac disease 1, 2 and type I diabetes 3, 4 . However, the role of this single polymorphism in disease initiation and progression remains poorly understood. The lack of Asp 57 creates a positively charged P9 pocket, which confers a preference for negatively charged peptides. Gluten lacks such peptides, but tissue transglutaminase (TG2) introduces negatively charged residues at defined positions into gluten T-cell epitopes by deamidating specific glutamine residues 5, 6 on the basis of their spacing to proline residues 7 . The commonly accepted model, proposing that HLA-DQ8 simply favours binding of negatively charged peptides, does not take into account the fact that TG2 requires inflammation for activation 8 and that T-cell responses against native gluten peptides are found 9, 10 , particularly in children 11 . Here we show that b57 polymorphism promotes the recruitment of T-cell receptors bearing a negative signature charge in the complementary determining region 3b (CDR3b) during the response against native gluten peptides presented by HLA-DQ8 in coeliac disease. These T cells showed a crossreactive and heteroclitic (stronger) response to deamidated gluten peptides. Furthermore, gluten peptide deamidation extended the T-cell-receptor repertoire by relieving the requirement for a charged residue in CDR3b. Thus, the lack of a negative charge at position b57 in MHC class II was met by negatively charged residues in the T-cell receptor or in the peptide, the combination of which might explain the role of HLA-DQ8 in amplifying the T-cell response against dietary gluten.
A specific assessment of the role of MHC class II alleles in antigenspecific T-cell responses is possible in coeliac disease, because it is caused by a single and well-defined antigen, gluten, which is present in wheat, rye and barley (reviewed in ref. 12) . Gluten is rich in glutamine and proline, and the high content of proline renders gluten resistant to intestinal enzymatic digestion, explaining the persistence of intact peptides for immune recognition. Notably, despite the presence of few negatively charged amino acid residues in gluten and the expression of other MHC alleles potentially capable of presenting gluten peptides, all gluten-specific CD4 1 T cells isolated from the intestinal mucosa of adult patients are restricted by HLA-DQ2 or HLA-DQ8 (refs 10, 13 and 14) , and most recognize a dominant peptide with a deamidated Gln-that is, a negatively charged Glu residue 5, 6 . To study the T-cell response to native and deamidated gluten peptides (Fig. 1a) , we immunized humanized HLA-DQ8 mice with the native 24-amino-acid gluten peptide 219-242 from the a2 (AJ133612) gliadin comprising the commonly recognized DQ8-a-I epitope (QGSFQPSQQ) 10 , or with a peptide deamidated at positions 229 and 237, the known targets of TG2 (ref. 6). As previously reported 15 , the deamidated peptide failed to induce superior effector or recall proliferative (Fig. 1b , left panel and Supplementary Fig. 1a , left panel) or cytokine ( Supplementary Fig. 1b , left panels) CD4
1 T-cell responses. Similar responses were also observed for lower, limiting doses of immunizing peptide (data not shown). However, under conditions of competition, when the two peptides were administered simultaneously, we found that the response against the deamidated peptide largely predominated over the native peptide (Fig. 1b , right panel and Supplementary Fig. 1 , right panels). When peptides with single Gln to Glu substitutions at position 229 or 237 (Fig. 1a) were compared in the same competition assay against the native peptide, the E237 peptide behaved like the deamidated peptide, whereas the E229 peptide resembled the native peptide (Fig. 1b middle and lower panels). In accordance with previous studies concluding that the Glu residue at position 229 binds to pocket 1 (P1) of HLA-DQ8, whereas Glu at position 237 binds to pocket 9 (P9) 6, 9, 16 , these results indicate that an acidic residue at position P9 confers a functional advantage with respect to immunization.
Using a panel of T-cell hybridomas derived from immunized lymph nodes, we compared the specificity and T-cell receptor (TCR) repertoire of CD4 1 T cells elicited by the native and the deamidated peptides. Immunization with native and deamidated peptides induced crossreactive T cells, in addition to T cells recognizing specifically one or the other form of the peptide. Notably, nearly a quarter of the hybridomas generated against the native peptide showed a 'heteroclitic' response 17 against the deamidated peptide, in that they responded much better to the deamidated than to the native peptide, with a shift in the dose response curve of up to 100-fold ( Fig. 1c and Supplementary Fig. 2 ). Immunization with the native peptide, however, did not induce T cells that recognized the deamidated peptide exclusively, confirming the absence of in vivo deamidation in this experimental setting. Importantly, a heteroclitic response was never observed after immunization with the deamidated peptide.
Analysis of the TCR repertoire (Fig. 1d) revealed that most T cells recognizing the native peptide-whether elicited by immunization with the native or the deamidated peptides-preferentially used a limited set of Vb chains including Vb11, Vb5, Vb14 and Vb2 T cells. T cells that exclusively recognized the native peptide predominantly expressed Vb11 (45%) and to a lesser degree Vb14 (15%), whereas T cells that equivalently recognized the two peptides mostly expressed Vb5 (75%). In marked contrast, T cells specific for the deamidated peptide showed a broad TCR repertoire with no preferential Vb (Fig. 1d) or Va chain use (data not shown).
By studying the response of T-cell hybridomas to amino-and carboxy-terminal deletion mutant peptides, we identified five different patterns. Most (82%) of the T cells specific for the native peptide responded to the minimal 229 QGSFQPSQQ 237 9-amino-acid determinant (pattern 1), whereas the remaining clones responded to the minimal 9-amino-acid 228 Table 1 , lower panel), indicating a requirement for the acidic residue at position 237. The diversity of response patterns observed with T cells specific for the deamidated peptide might be due to shifts in the peptide register, as the structure of MHC class II molecules allows peptides to frameshift within the MHC groove 18 . Alternatively, a single register might be occupied by the deamidated peptide, but the diverse TCRs could contact different residues. Altogether, these results indicate that recognition of the native peptide imposes strict requirements leading to limited TCR use, whereas by displaying several epitopes by a yet undetermined mechanism, the deamidated peptide recruits a far broader TCR repertoire.
Examination of TCR sequences revealed the notable conservation of a negative charge at position 3 of CDR3b in most T cells recognizing the native peptide, including 92% of those specific for the native peptide, and 60-92% of those that responded to both the native and the deamidated peptides (Table 1) . Importantly, 91% of the negative charges were non-germline-encoded, indicating an antigen-driven selection process (Supplementary Table 2 ). During TCR V(D)J recombination, further diversity is generated by the stochastic addition and deletion of palindromic and non-germline nucleotides at the coding joints between the gene segments. Specifically, here more than 35% of the non-germline-encoded negatively charged residues resulted from one non-germline nucleotide addition, 19% from three palindromic nucleotide additions and the rest from two non-germline, three non-germline, or one palindromic nucleotide additions and from the combination of two palindromic and one non-germline nucleotide additions (Supplementary Table 2 ). Interestingly, published TCR sequences from early islet infiltrates in NOD mice are also characterized by a conserved negative charge at position 3 of the CDR3b loop 19, 20 . In contrast, only 29% of T cells specific for the deamidated gluten peptide had a negative charge at that position (Table 1 ). A possible model accounting for these findings is that HLA-DQ8-and IA g7 -restricted TCRs against peptides lacking acidic residues must use a negative charge in their CDR3b to stabilize peptide-MHC (pMHC) complexes through chargecharge interactions.
In vitro assay distinct, yet overlapping TCR repertoires. a, Humanized HLA-DQ8 transgenic mice were immunized with native (Q) and deamidated (E) versions of the 24-amino-acid gluten peptide a2-219-242 and two E peptide analogues with a Glu residue either in position 229 (E229) or 237 (E237). The draining lymph nodes were collected 8 days after immunization and CD4 1 T cells were purified to perform functional assays and derive a2-219-242 gluten-peptide-specific HLA-DQ8-restricted T-cell hybridomas. b, Purified CD4 1 T cells were tested for proliferative in vitro responses with the indicated peptide at the specified concentrations in the presence of irradiated (30 Gy) spleen cells from non-immunized humanized HLA-DQ8 mice. Responses are given in c.p.m. from the mean 3 H-thymidine incorporation in triplicate cultures 6 s.d. n 5 3 mice per each condition of immunization. The data are representative of three independent experiments for upper panels, and two independent experiments for middle and lower panels. c, A panel of a2-219-242 gluten-peptide-specific CD4
1 T hybridomas was derived after immunization with native (Q ) or deamidated (E) peptide alone. Hybridoma reactivity was defined by measuring IL-2 secretion. Q and E hybridomas responded exclusively to native and deamidated peptides, respectively. Q 5 E, hybridomas responded equally well to native and deamidated peptides; Q . E, hybridomas responded 10-100 times better to native than to deamidated peptide; E . Q, hybridomas responded 10-100 times better to deamidated than to native peptide. The percentage of T-cell hybridomas obtained in each class is indicated. Importantly, assessing the quality of the immunization, no E-specific hybridomas were obtained after Q immunization, and conversely no Q-specific hybridomas were obtained after E immunization To test whether the negative charge at position 3 of CDR3b is required for recognition of the native peptide, we generated a TCR mutant lacking the conserved negative charge (Fig. 2a) , as well as a negatively charged HLA-DQ8 mutant in which an Asp was introduced at position b57 (Fig. 2b) . The TCR was obtained from a representative Vb5.1/Va17 hybridoma that responded equivalently to the native and deamidated peptides and was retrovirally transferred
of recognition of the native peptide, whereas the response to the deamidated peptide was preserved (Fig. 2a, middle panel) . As a control, mutation of a non-conserved negative charge at position 8 of CDR3b (Vb5.1 (DRN)) did not alter the response to either native or deamidated peptides (Fig. 2a, right panel) . We next performed the reciprocal experiment in which HLA-DQ8 was mutated to introduce an Asp at position b57. Using T-cell hybridomas responding equally well to native and deamidated peptides, we observed a marked loss of response to the native peptide (Fig. 2b, left panel) . Loss of recognition of the native peptide with the Asp 57 DQ8 mutant was also confirmed with three hybridomas recognizing selectively native peptides (data not shown). In contrast, recognition of the deamidated peptide was only moderately affected (Fig. 2b, right panel) , consistent with previous studies showing that MHC alleles carrying an Asp at position b57 can bind peptides harbouring acidic residues. These results support the hypothesis that HLA-DQ8 b57 polymorphism can elicit strong responses against non-negatively charged peptides by recruiting TCRs that express a negative charge at position 3 of CDR3b.
The amplitude of the T-cell response results from the combined strength of the binding of peptide to MHC and the binding of TCR to pMHC complexes. The strong response elicited by the native peptide was surprising given the lack of a negative charge to match the positive P9 pocket in HLA-DQ8. Indeed, whereas the deamidated peptide readily competed with the binding of indicator peptide to HLA-DQ8, binding of the native peptide was below detection (Supplementary Fig. 3a ). When indirectly measured by hybridoma stimulation using a clone responding to both peptides, the binding of the native peptide exhibited similar on-rate but increased off-rate ( Supplementary Fig. 3b ). Overall these results are in accordance with 
CDR3b sequences from T-cell hybridomas characterized in Fig. 1 are presented. Hybridomas names are indicated in capital letter Q when they were derived from immunization with native peptide, and in capital letter E when they were derived from immunization with deamidated peptide. GenBank accession numbers are in parentheses. Junctionally encoded amino acids are shown as lower-case. Amino acid residues at position 3 are bold when they are negatively charged. previous observations showing strong in vivo and in vitro T-cell responses against peptides for which no binding to MHC could be detected by direct binding assays 21, 22 . Furthermore, our data suggest that the instability of complexes between native peptide and HLA-DQ8 is compensated by the presence of a negatively charged residue in the CDR3b loop. In agreement with these findings, the presence of T cells during the short incubation time (1 h) of antigen-presenting cells with gluten peptides influenced the magnitude of their response against the native but not the deamidated peptide ( Supplementary  Fig. 3c ).
Because the native gluten peptides recruit a T-cell population that is not only largely crossreactive but also substantially heteroclitic against the deamidated peptides, these cells could be recruited and continuously activated once inflammation is triggered and TG2 is activated to produce deamidated peptide. Consistent with this model, quantification of the CD4 1 T-cell response by enzyme-linked immunospot (ELISPOT) showed that the frequency of T cells recognizing the deamidated peptide was consistently highly increased after immunization with a mixture of native and deamidated peptides (Fig. 3) .
To assess the pathogenic relevance of our findings further, we examined the TCR structure of human T-cell clones specific for the native DQ8-a-I epitope (QGSFQPSQQ). Notably, six out of six human T-cell clones, obtained from two independent research centres in Leiden and Oslo, expressed a TCR with a non-germline-encoded acidic residue precisely at position 3 of their CDR3b (Table 2 ). All these negatively charged residues were non-germline encoded and resulted from one non-germline (16.7%), two non-germline (33.3%), two palindromic (33.3%) and three non-germline (16.7%) nucleotide additions (Supplementary Table 3 ). In contrast, none of the three non gluten-specific T-cell clones derived from the same patients had this signature charge in their CDR3b (Table 3) . To integrate these results in a more general context, we analysed 125 published TCR sequences obtained from HLA-DQ8 individuals with type I diabetes (n 5 116), Birch (n 5 5) and nickel (n 5 1) allergy, or HIV infection (n 5 3) and found that only 17 had a negatively charged residue at position 3 of the CDR3b loop. Interestingly, all of these 17 TCRs originated from the type I diabetes patients (data not shown).
This study reveals a new mechanism of peptide recognition in the context of HLA-DQ8, the MHC class II allele that predisposes to both type I diabetes and coeliac disease. The P9 pocket of HLA-DQ8, lacking the canonical Asp 57 found in other alleles, has the potential to interact not only with peptides harbouring an acidic residue at the P9 position, but also with TCRs harbouring a negative charge in their CDR3b loop. The potent response generated in vivo against native peptides with extremely low affinity for HLA-DQ8 may be explained by the ability of these TCRs to stabilize pMHC complexes. A large proportion of the TCRs recruited by native peptides display a crossreactive heteroclitic response to the deamidated peptide, which binds strongly to HLA-DQ8. Furthermore, because deamidated peptides do not impose charge constraints on the TCR, they can recruit an additional TCR repertoire. Consequently, the magnitude of the response against the deamidated peptide is increased under conditions in which native and deamidated peptides are both present. This may be particularly relevant in the context of coeliac disease, because TG2 is probably unevenly activated once inflammation is initiated. Furthermore, the magnitude of the T-cell response is viewed as a limiting factor for disease development 23, 24 . In the absence of a disease model of coeliac disease, it is at present not possible to assess whether this process is important for disease onset, disease progression or other aspects of the disease. It also remains to be determined whether DQ b57 polymorphism also contributes to the strong association of coeliac disease with HLA-DQ2.
It is tempting to speculate that similar mechanisms may explain the association of type I diabetes with HLA-DQ8. The TCR repertoire of early pancreatic islet infiltrate is also characterized by the frequent presence of a negative charge at position 3 of CDR3b 19, 20, 25 . Furthermore, our preliminary studies suggest that TG2 activity is significantly increased in the pancreas, but not in the draining pancreatic lymph node and the spleen of 12-week-old NOD mice that have ongoing pancreatic inflammation (B.J. and L.T., unpublished observations). The ability to present native and deamidated peptides and recruit crossreactive TCR repertoires directly linked to the polymorphism at position b57 may underlie the remarkable association of HLA-DQ8 with severe immunopathology in mouse and human.
METHODS SUMMARY
Detailed methods are found in the Supplementary Information. Humanized HLA-DQ8 transgenic mice 15 were immunized in the footpad with immunodominant native (Q) and deamidated (E) a2-219-242 gluten peptide versions of this peptide with glutamates in position 229 and/or 237. T-cell proliferation, cytokine enzyme-linked immunoabsorbent (ELISA) and IFN-c ELISPOT assays were performed to analyse the immune response to native and deamidated peptides. T-cell hybridomas were generated after immunization with native and deamidated gluten peptides and their specificity was characterized by Humanized HLA-DQ8 transgenic mice were immunized with Q or E gluten peptides alone, or in combination. Eight days after immunization CD4 1 T cells were purified and re-challenged in vitro with 32.3 mM Q or E peptides. The frequency of IFN-cproducing cells was assessed using ELISPOT. Each bar represents the mean spot number of triplicates 6 s.d. **P , 0.001; data are representative of three independent experiments, each comprising three mice for each type of immunization. DR3b sequences of gluten-specific HLA-DQ8-restricted and non-gluten-reactive control T-cell clones are presented. T-cell clones were obtained from research centres in Leiden (Spec16, 12, 13, 22 and 1) and Oslo (TCC360.11, TCC360.8, TCC489.2.1.4 and TCC360.10). Spec12 and Spec13 expressed two functional Vb chains, which can be explained by the absence of allelic exclusion. GenBank accession numbers are in parentheses. Junctionally encoded amino acids are presented in lower-case. Amino acid residues at position 3 are bold when they are negatively charged.
measuring IL-2 release 26 . TCR CDR3b sequencing was performed after TCR b-chain amplification with a set of TCR variable region (Vb) sense and a TCR constant region (Cb) antisense consensus primers as described 27 . TCR b-chain sequences were identified as TCR gene segments using BLAST and aligned/ analysed using International Immunogenetics Database (http://imgt.cines.fr). The nomenclature is according to the World Health OrganizationInternational Union of Immunological Societies (IUIS) nomenclature 28 . Transfectants expressing wild-type and mutated Va17 and Vb5.1 TCR of hybridomas that responded equally well to native and deamidated peptides were generated by retroviral transduction of T-cell hybridoma variant 58a 2 b 2 (ref. 29) . The soluble versions of wild-type and mutant DQ8 molecules were produced as previously described 30 . Human T-cell clones specific for the a2-219-242 epitope were established from intestinal biopsies of DQ8-positive coeliac disease patients as previously described 10, 13 . Received 21 July; accepted 6 October 2008.
